Effects of Adverse Events on the Projected Population Benefits and Cost-effectiveness of Using Live Attenuated Influenza Vaccine in Children Aged 6 Months to 4 Years

Authors:
  • MMMartin I. Meltzer
    Martin I. Meltzer
  • AFAnthony Fiore
    Anthony Fiore
  • SEScott Epperson
    Scott Epperson
  • CBCarolyn B. Bridges
    Carolyn B. Bridges
  • VHVirginia Hinrichsen
    Virginia Hinrichsen
  • TLTracy A. Lieu
    Tracy A. Lieu

Abstract
ObjectiveTo evaluate the effect of adverse events associated with live attenuated influenza vaccine (LAIV) in children younger than 5 years on the cost-effectiv

This publication has 27 references indexed in Scilit: